These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 20021476

  • 41. Monitoring microemboli during cardiopulmonary bypass with the EDAC quantifier.
    Lynch JE, Wells C, Akers T, Frantz P, Garrett D, Scott ML, Williamson L, Agnew B, Lynch JK.
    J Extra Corpor Technol; 2010 Sep; 42(3):212-8. PubMed ID: 21114224
    [Abstract] [Full Text] [Related]

  • 42. Handling ability of gaseous microemboli of two pediatric arterial filters in a simulated CPB model.
    Strother A, Wang S, Kunselman AR, Ündar A.
    Perfusion; 2013 May; 28(3):244-52. PubMed ID: 23359037
    [Abstract] [Full Text] [Related]

  • 43. Microemboli in our bypass circuits: a contemporary audit.
    Willcox TW, Mitchell SJ.
    J Extra Corpor Technol; 2009 Dec; 41(4):P31-7. PubMed ID: 20092085
    [Abstract] [Full Text] [Related]

  • 44. An in vitro evaluation of gaseous microemboli handling by contemporary venous reservoirs and oxygenator systems using EDAC.
    Stanzel RD, Henderson M.
    Perfusion; 2016 Jan; 31(1):38-44. PubMed ID: 25987549
    [Abstract] [Full Text] [Related]

  • 45. Detection and elimination of microemboli related to cardiopulmonary bypass.
    Groom RC, Quinn RD, Lennon P, Donegan DJ, Braxton JH, Kramer RS, Weldner PW, Russo L, Blank SD, Christie AA, Taenzer AH, Forest RJ, Clark C, Welch J, Ross CS, O'Connor GT, Likosky DS, Northern New England Cardiovascular Disease Study Group.
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):191-8. PubMed ID: 20031837
    [Abstract] [Full Text] [Related]

  • 46. Evaluation of Capiox FX05 oxygenator with an integrated arterial filter on trapping gaseous microemboli and pressure drop with open and closed purge line.
    Qiu F, Peng S, Kunselman A, Ündar A.
    Artif Organs; 2010 Nov; 34(11):1053-7. PubMed ID: 21137158
    [Abstract] [Full Text] [Related]

  • 47. In-Vitro Evaluation of Two Types of Neonatal Oxygenators in Handling Gaseous Microemboli and Maintaining Optimal Hemodynamic Stability During Cardiopulmonary Bypass.
    Marupudi N, Wang S, Canêo LF, Jatene FB, Kunselman AR, Undar A.
    Braz J Cardiovasc Surg; 2016 Nov; 31(5):343-350. PubMed ID: 27982342
    [Abstract] [Full Text] [Related]

  • 48. Measurement of gaseous microemboli in the prime before the initiation of cardiopulmonary bypass.
    Husebråten IM, Fiane AE, Ringdal MIL, Thiara APS.
    Perfusion; 2018 Jan; 33(1):30-35. PubMed ID: 28784030
    [Abstract] [Full Text] [Related]

  • 49. Evaluation of Quadrox-i and Capiox FX neonatal oxygenators with integrated arterial filters in eliminating gaseous microemboli and retaining hemodynamic properties during simulated cardiopulmonary bypass.
    Lin J, Dogal NM, Mathis RK, Qiu F, Kunselman A, Ündar A.
    Perfusion; 2012 May; 27(3):235-43. PubMed ID: 22337759
    [Abstract] [Full Text] [Related]

  • 50. Microemboli detection on extracorporeal bypass circuits.
    Lynch JE, Riley JB.
    Perfusion; 2008 Jan; 23(1):23-32. PubMed ID: 18788214
    [Abstract] [Full Text] [Related]

  • 51. Blood temperature management and gaseous microemboli creation: an in-vitro analysis.
    Sleep J, Syhre I, Evans E.
    J Extra Corpor Technol; 2010 Sep; 42(3):219-22. PubMed ID: 21114225
    [Abstract] [Full Text] [Related]

  • 52. In vitro evaluation of Capiox FX05 and RX05 oxygenators in neonatal cardiopulmonary bypass circuits with varying venous reservoir and vacuum-assisted venous drainage levels.
    Sathianathan S, Nasir R, Wang S, Kunselman AR, Ündar A.
    Artif Organs; 2020 Jan; 44(1):28-39. PubMed ID: 30512218
    [Abstract] [Full Text] [Related]

  • 53. Do surface-modifying additive circuits reduce the rate of cerebral microemboli during cardiopulmonary bypass?
    Rodriguez RA, Watson MI, Nathan HJ, Rubens F.
    J Extra Corpor Technol; 2006 Sep; 38(3):216-9. PubMed ID: 17089507
    [Abstract] [Full Text] [Related]

  • 54. Microemboli detection and classification by innovative ultrasound technology during simulated neonatal cardiopulmonary bypass at different flow rates, perfusion modes, and perfusate temperatures.
    Schreiner RS, Rider AR, Myers JW, Ji B, Kunselman AR, Myers JL, Undar A.
    ASAIO J; 2008 Sep; 54(3):316-24. PubMed ID: 18496283
    [Abstract] [Full Text] [Related]

  • 55. Continuous detection of microemboli during cardiopulmonary bypass in animals and man.
    Clark RE, Dietz DR, Miller JG.
    Circulation; 1976 Dec; 54(6 Suppl):III74-8. PubMed ID: 991427
    [Abstract] [Full Text] [Related]

  • 56. Prebypass filtration of cardiopulmonary bypass circuits: an outdated technique?
    Merkle F, Böttcher W, Hetzer R.
    Perfusion; 2003 Mar; 18 Suppl 1():81-8. PubMed ID: 12708770
    [Abstract] [Full Text] [Related]

  • 57. Reduced amount of gaseous microemboli in the arterial line of minimized extracorporeal circulation systems compared with conventional extracorporeal circulation.
    Bauer A, Schaarschmidt J, Anastasiadis K, Carrel T.
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):152. PubMed ID: 24047711
    [No Abstract] [Full Text] [Related]

  • 58. Air removal capacity of two different minimal invasive ECC systems: an in vitro comparison.
    Stehouwer MC, de Vroege R.
    Perfusion; 2019 Oct; 34(7):561-567. PubMed ID: 30915891
    [Abstract] [Full Text] [Related]

  • 59. In vitro evaluation of gaseous microemboli handling of cardiopulmonary bypass circuits with and without integrated arterial line filters.
    Liu S, Newland RF, Tully PJ, Tuble SC, Baker RA.
    J Extra Corpor Technol; 2011 Sep; 43(3):107-14. PubMed ID: 22164448
    [Abstract] [Full Text] [Related]

  • 60. Antithrombin-heparin covalent complex reduces microemboli during cardiopulmonary bypass in a pig model.
    Klement P, Berry LR, Liao P, Wood H, Tressel P, Smith LJ, Haque N, Weitz JI, Hirsh J, Paredes N, Chan AK.
    Blood; 2010 Dec 16; 116(25):5716-23. PubMed ID: 20817849
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.